231 related articles for article (PubMed ID: 34555251)
21. Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding.
Terasawa H; Matsumoto K; Tanaka T; Tomoda T; Ogawa T; Ishihara Y; Kikuchi T; Obata T; Oda T; Matsumi A; Miyamoto K; Morimoto K; Fujii Y; Yamazaki T; Uchida D; Horiguchi S; Tsutsumi K; Kato H; Otsuka M
Pancreatology; 2023 Dec; 23(8):988-995. PubMed ID: 37951728
[TBL] [Abstract][Full Text] [Related]
22. Analyzing S100A6 expression in endoscopic ultrasonography-guided fine-needle aspiration specimens: a promising diagnostic method of pancreatic cancer.
Zihao G; Jie Z; Yan L; Jing Z; Jing C; Xue L; Jing Z; Heng LW; Ru G; Jianyu H
J Clin Gastroenterol; 2013 Jan; 47(1):69-75. PubMed ID: 22914344
[TBL] [Abstract][Full Text] [Related]
23. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
[TBL] [Abstract][Full Text] [Related]
24. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract][Full Text] [Related]
25. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
Xu Y; Hu D; Zhu Q; Sun Y
Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
[TBL] [Abstract][Full Text] [Related]
26. EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study.
Hedenström P; Demir A; Khodakaram K; Nilsson O; Sadik R
Scand J Gastroenterol; 2018 Feb; 53(2):231-237. PubMed ID: 29301477
[TBL] [Abstract][Full Text] [Related]
27. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
28. EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Cao C; Kong MX; Kapali M; Moezardalan K; Shi Q; Azarm A; Lai J
Anticancer Res; 2020 Aug; 40(8):4401-4404. PubMed ID: 32727769
[TBL] [Abstract][Full Text] [Related]
29. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasound-guided fine needle biopsy specimens: an interobserver agreement study.
Notohara K; Kamisawa T; Furukawa T; Fukushima N; Uehara T; Kasashima S; Iwasaki E; Kanno A; Kawashima A; Kubota K; Kuraishi Y; Motoya M; Naitoh I; Nishino T; Sakagami J; Shimizu K; Tomono T; Aishima S; Fukumura Y; Hirabayashi K; Kojima M; Mitsuhashi T; Naito Y; Ohike N; Tajiri T; Yamaguchi H; Fujiwara H; Ibuki E; Kobayashi S; Miyaoka M; Nagase M; Nakashima J; Nakayama M; Oda S; Taniyama D; Tsuyama S; Watanabe S; Ikeura T; Kawa S; Okazaki K
Virchows Arch; 2022 Mar; 480(3):565-575. PubMed ID: 34820715
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic efficacy of liquid-based cytology for solid pancreatic lesion samples obtained with endoscopic ultrasound-guided fine-needle aspiration: Propensity score-matched analysis.
Hashimoto S; Taguchi H; Higashi M; Hatanaka K; Fujita T; Iwaya H; Nakazawa J; Arima S; Iwashita Y; Sasaki F; Nasu Y; Kanmura S; Ido A
Dig Endosc; 2017 Jul; 29(5):608-616. PubMed ID: 28160342
[TBL] [Abstract][Full Text] [Related]
31. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma.
Lai JP; Yue Y; Zhang W; Zhou Y; Frishberg D; Jamil LH; Mirocha JM; Guindi M; Balzer B; Bose S; Cao D; Lo S; Fan X; Rutgers JK
Pancreatology; 2017; 17(4):617-622. PubMed ID: 28501471
[TBL] [Abstract][Full Text] [Related]
32. miR-18a and miR-106a Signatures in Plasma Small EVs Are Promising Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma.
Xu X; Bhandari K; Xu C; Morris K; Ding WQ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108374
[TBL] [Abstract][Full Text] [Related]
33. Metachronous Pancreatic Ductal Adenocarcinoma with Adjacent Serous Cystadenoma that Was Preoperatively Diagnosed by EUS-FNA: A Case Report and Review of the Literature.
Yoshida M; Naitoh I; Hayashi K; Jinno N; Natsume M; Hori Y; Kato A; Kachi K; Asano G; Matsuo Y; Takahashi S; Kataoka H
Intern Med; 2020 Mar; 59(5):649-656. PubMed ID: 31735797
[TBL] [Abstract][Full Text] [Related]
34. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma.
Han Y; Drobisch P; Krüger A; William D; Grützmann K; Böthig L; Polster H; Seifert L; Seifert AM; Distler M; Pecqueux M; Riediger C; Plodeck V; Nebelung H; Weber GF; Pilarsky C; Kahlert U; Hinz U; Roth S; Hackert T; Weitz J; Wong FC; Kahlert C
J Hematol Oncol; 2023 Feb; 16(1):7. PubMed ID: 36737824
[TBL] [Abstract][Full Text] [Related]
35. Analysis of BRCAness with multiplex ligation-dependent probe amplification using formalin-fixed and paraffin-embedded pancreatic ductal adenocarcinoma tissue obtained via endoscopic ultrasound-guided fine-needle aspiration biopsy.
Okuwaki K; Masutani H; Imaizumi H; Yoshida T; Kida M; Iwai T; Yamauchi H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Koizumi W
Pancreatology; 2019 Apr; 19(3):419-423. PubMed ID: 30819577
[TBL] [Abstract][Full Text] [Related]
36. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer.
Brand RE; Adai AT; Centeno BA; Lee LS; Rateb G; Vignesh S; Menard C; Wiechowska-Kozłowska A; Bołdys H; Hartleb M; Sanders MK; Munding JB; Tannapfel A; Hahn SA; Stefańczyk L; Tsongalis GJ; Whitcomb DC; Conwell DL; Morisset JA; Gardner TB; Gordon SR; Suriawinata AA; Lloyd MB; Wylie D; Labourier E; Andruss BF; Szafranska-Schwarzbach AE
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1717-23. PubMed ID: 24662333
[TBL] [Abstract][Full Text] [Related]
37. Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using perfusion parameters? A pilot study.
Constantin AL; Cazacu I; Burtea DE; Cherciu Harbiyeli I; Bejinariu N; Popescu C; Serbanescu M; Tabacelia D; Copaescu C; Bhutani M; Stroescu C; Saftoiu A
Med Ultrason; 2022 Dec; 24(4):393-398. PubMed ID: 36047426
[TBL] [Abstract][Full Text] [Related]
38. P53 immunolabeling in EUS-FNA biopsy can predict low resection rate and early recurrence in resectable or borderline resectable pancreatic cancer treated with neoadjuvant therapy.
Oshima M; Okano K; Kamada H; Suto H; Ando Y; Ibuki E; Ishikawa R; Masaki T; Haba R; Suzuki Y
J Hepatobiliary Pancreat Sci; 2023 Jun; 30(6):802-814. PubMed ID: 36448271
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with a KRAS mutation assay using allelic discrimination improves the diagnosis of pancreatic cancer.
Bournet B; Selves J; Grand D; Danjoux M; Hanoun N; Cordelier P; Buscail L
J Clin Gastroenterol; 2015 Jan; 49(1):50-6. PubMed ID: 24798941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
